O-LINKED CARBOHYDRATE OF RECOMBINANT VONWILLEBRAND-FACTOR INFLUENCES RISTOCETIN-INDUCED BINDING TO PLATELET GLYCOPROTEIN-1B

被引:45
作者
CAREW, JA
QUINN, SM
STODDART, JH
LYNCH, DC
机构
[1] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
关键词
CHINESE HAMSTER OVARY CELLS; GLYCOSYLATION; PROTEIN BINDING; PLATELET AGGLUTINATION; ENDOTHELIUM;
D O I
10.1172/JCI116112
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
By transfecting the full-length CDNA for human von Willebrand factor (vWf) into a line of Chinese hamster ovary cells with a defect in carbohydrate metabolism, we have prepared recombinant vWf specifically lacking O-linked carbohydrates. We have compared this under-glycosylated protein to fully glycosylated recombinant vWf with respect to several structural and binding properties. vWf deficient in O-linked glycans was synthesized, assembled into multimers, and secreted in an apparently normal manner and was not prone to degradation in the extracellular milieu. It did not differ from fully glycosylated vWf in ability to bind to heparin or to collagen type I but did interact less well with glycoprotein 1b on formalin-fixed platelets. This decreased interaction was evidenced in both a lessened overall binding to platelets and in diminished capacity to promote platelet agglutination, in the presence of ristocetin. In contrast, no difference was seen in platelet binding in the presence of botrocetin. These data indicate a possible role for O-linked carbohydrates in the vWf-glycoprotein 1b interaction promoted by ristocetin and suggest that abnormalities in carbohydrate modification might contribute to the altered ristocetin-dependent reactivity between vWf and platelets described for some variant forms of von Willebrand disease.
引用
收藏
页码:2258 / 2267
页数:10
相关论文
共 57 条
[11]   DISTINCT ABNORMALITIES IN THE INTERACTION OF PURIFIED TYPE-IIA AND TYPE-IIB VONWILLEBRAND-FACTOR WITH THE 2 PLATELET BINDING-SITES, GLYCOPROTEIN COMPLEX-IB-IX AND COMPLEX-IIB-IIIA [J].
DEMARCO, L ;
MAZZUCATO, M ;
DEROIA, D ;
CASONATO, A ;
FEDERICI, AB ;
GIROLAMI, A ;
RUGGERI, ZM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :785-792
[12]   PROPOLYPEPTIDE OF VONWILLEBRAND-FACTOR CIRCULATES IN BLOOD AND IS IDENTICAL TO VONWILLEBRAND ANTIGEN-II [J].
FAY, PJ ;
KAWAI, Y ;
WAGNER, DD ;
GINSBURG, D ;
BONTHRON, D ;
OHLSSONWILHELM, BM ;
CHAVIN, SI ;
ABRAHAM, GN ;
HANDIN, RI ;
ORKIN, SH ;
MONTGOMERY, RR ;
MARDER, VJ .
SCIENCE, 1986, 232 (4753) :995-998
[13]  
FOSTER PA, 1987, J BIOL CHEM, V262, P8443
[14]  
FUJIMURA Y, 1991, BLOOD, V77, P113
[15]   ISOLATION AND CHEMICAL CHARACTERIZATION OF 2 STRUCTURALLY AND FUNCTIONALLY DISTINCT FORMS OF BOTROCETIN, THE PLATELET COAGGLUTININ ISOLATED FROM THE VENOM OF BOTHROPS-JARARACA [J].
FUJIMURA, Y ;
TITANI, K ;
USAMI, Y ;
SUZUKI, M ;
OYAMA, R ;
MATSUI, T ;
FUKUI, H ;
SUGIMOTO, M ;
RUGGERI, ZM .
BIOCHEMISTRY, 1991, 30 (07) :1957-1964
[16]  
FUJIMURA Y, 1986, J BIOL CHEM, V261, P381
[17]  
FUJIMURA Y, 1987, J BIOL CHEM, V262, P1734
[18]  
FUJIMURA Y, 1987, BLOOD, V70, P985
[19]  
GIRMA JP, 1987, BLOOD, V70, P605
[20]  
GIRMA JP, 1990, THROMB HAEMOSTASIS, V64, P326